The Latest Breaking News from Benzinga

Streaming pioneer Roku, Inc. (NASDAQ:ROKU) introduced Howdy on Tuesday, a new subscription video-on-demand service priced at just $2.99 per month.

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) stock is falling on Tuesday after the company’s pain data overshadowed strong second-quarter earnings.

Fellow Health just raised $24 million in a Series B funding round, bringing its cash haul across multiple offerings to $48 million. The San Leandro, California startup advances male reproductive health through "patient-centric testing solutions" and plans to use the capital infusion to expand its mail-in semen analysis services.  

ZetaChain's (CRYPTO: ZETA) latest integration with the Sui (CRYPTO: SUI) blockchain could bring real capital flows and application-level traction from native Bitcoin (CRYPTO: BTC), not just infrastructure optics, according to Jonathan Covey, a core contributor at ZetaChain.

On Tuesday, Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) reported second-quarter adjusted earnings of $1.44, up 50% year over year, beating the consensus of 85 cents and sales of $825.41 million, up 16%, beating the consensus of $760.39 million.

Artificial intelligence and digital tools are transforming the insurance landscape, but contrary to popular belief, technology isn't making human agents obsolete — it's making them more essential than ever.

Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc. (NASDAQ:PLTR), the top-performing SP 500 stock of 2025.

Jacobs Solutions Inc (NYSE:J) stock gained on Tuesday after the company reported third-quarter 2025 results. Revenue rose 5.1% year-over-year to $3.03 billion, topping the $2.23 billion analyst consensus estimate.

Molson Coors Beverage Company (NYSE:TAP) reported second-quarter results on Tuesday, with adjusted earnings per share of $2.05, beating the analyst consensus estimate of $1.86.